By Tony Fong
NEW YORK (GenomeWeb News) – As next-generation sequencing makes its way into the clinic, platform vendors will need to change their operations to accommodate the shift, company executives said this week at the Burrill Personalized Medicine Meeting held in Burlingame, Calif.
Those changes include new emphases on different geographies, as well as disease areas, and new approaches to handling the data.